8/25/25 08:50  | 8/22/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Myers Scott Dunseth | CA | D |  | P | 41 | 10.82 | 0 | 4 | 12 | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/22/25 20:49  | 8/21/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Deep Track Biotechnology Master Fund, Ltd. | E9 | T |  | S.m | -22,352 | 10.82 | 0 | -2,065 | -12 | 15,726 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/26/25 17:04  | 3/24/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 68 | 6.81 | 0 | 10 |  | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/26/25 17:04  | 3/24/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -140 | 14.00 | 0 | -10 | -55 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/20/25 18:15  | 3/18/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -190 | 13.58 | 0 | -14 | -63 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/10/25 21:44  | 3/7/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -471 | 14.39 | 0 | -33 | -60 | 22 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/21/25 16:39  | 2/18/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 17 | 85 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/25 19:52  | 2/18/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 12 | 18 | 77 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/25 19:29  | 2/18/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 15 | 113 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/25 19:21  | 2/18/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 55 | 27 | 261 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/25 19:16  | 2/18/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 23 | 70 | 55 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/25 17:24  | 2/13/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 63 | 35 | 242 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/25 17:14  | 2/13/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 14 | 127 | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/25 17:13  | 2/13/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 27 | 162 | 43 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/25 17:10  | 2/13/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 16 | 587 | 19 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/25 17:08  | 2/13/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 13 | 23 | 70 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/12/25 17:37  | 2/10/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 9 | 47 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/12/25 17:35  | 2/10/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | M.d | 0 | 0.00 | 0 | 5 | 48 | 14 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/12/25 17:01  | 2/10/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 21 | 11 | 211 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/12/25 16:59  | 2/10/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 | 197 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/12/25 16:57  | 2/10/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 4 | 8 | 61 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/12/25 16:49  | 2/10/25  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | VP Finan | M.d | 0 | 0.00 | 0 | 7 |  | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/3/24 17:37  | 5/31/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | S | -43 | 11.93 | 0 | -4 | -9 | 37 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/28/24 20:18  | 5/24/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | M.d | 44 | 5.90 | 0 | 8 | 23 | 41 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/24 17:25  | 3/1/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 74 | 10.45 | 0 | 7 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/24 17:25  | 3/1/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -262 | 12.78 | 0 | -21 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/24 16:42  | 2/16/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 7 | 99 | 13 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 20:56  | 2/10/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 9 | 73 | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 20:46  | 2/10/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 4 | 8 | 59 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 17:25  | 2/10/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 21 | 12 | 201 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 17:21  | 2/10/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 7 | 270 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 17:16  | 2/10/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 |  | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/7/24 20:41  | 2/3/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.ad | 0 | 0.00 | 0 | 10 | 22 | 56 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/24 16:45  | 2/3/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 18 |  | 15 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/24 16:33  | 2/4/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 30 | 18 | 191 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/24 16:32  | 2/3/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 10 | 22 | 56 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/6/24 16:31  | 2/3/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 8 |  | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/8/24 18:48  | 1/4/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 14 | 9.41 | 0 | 2 | 3 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/8/24 18:48  | 1/4/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -23 | 15.00 | 0 | -2 | -3 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/24 19:04  | 1/2/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 49 | 5.42 | 0 | 9 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/24 19:04  | 1/2/24  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -130 | 14.45 | 0 | -9 | -74 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/5/23 19:12  | 12/1/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/5/23 19:12  | 12/1/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -271 | 13.56 | 0 | -20 | -86 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/7/23 17:16  | 11/3/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/7/23 17:16  | 11/3/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -300 | 15.00 | 0 | -20 | -86 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/3/23 16:32  | 11/1/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/3/23 16:32  | 11/1/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -282 | 14.12 | 0 | -20 | -86 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/11/23 20:53  | 10/10/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 17 | 9.41 | 0 | 2 | 4 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/11/23 20:53  | 10/10/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -26 | 15.01 | 0 | -2 | -3 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/4/23 16:35  | 10/2/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 217 | 5.42 | 0 | 40 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/4/23 16:35  | 10/2/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -595 | 14.88 | 0 | -40 | -93 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/3/23 20:26  | 10/2/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 47 | 9.41 | 0 | 5 | 11 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/3/23 20:26  | 10/2/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -75 | 15.03 | 0 | -5 | -9 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/5/23 17:05  | 9/1/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 108 | 5.42 | 0 | 20 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/5/23 17:05  | 9/1/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -290 | 14.48 | 0 | -20 | -86 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/23 18:47  | 8/24/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 6 | 9.41 | 0 | 1 | 1 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/23 18:47  | 8/24/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -9 | 15.02 | 0 | -1 | -1 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/24/23 12:30  | 8/23/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 328 | 9.41 | 0 | 35 | 231 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/24/23 12:30  | 8/23/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -523 | 15.01 | 0 | -35 | -41 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/23 16:31  | 8/8/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S | -21,585 | 14.39 | 0 | -1,500 | -62 | 926 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/23 11:57  | 8/8/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 177 | 4.41 | 0 | 40 |  | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/23 11:57  | 8/8/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -595 | 14.87 | 0 | -40 | -93 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/9/23 19:26  | 8/8/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 24 | 9.41 | 0 | 3 | 5 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/9/23 19:26  | 8/8/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | S.d | -39 | 15.05 | 0 | -3 | -5 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/8/23 16:23  | 8/7/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 66 | 8.16 | 0 | 8 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/8/23 16:23  | 8/7/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -117 | 14.55 | 0 | -8 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/16/23 16:30  | 6/14/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S | -6,340 | 12.68 | 0 | -500 | -17 | 2,426 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/23 16:30  | 5/18/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S | -10,550 | 10.55 | 0 | -1,000 | -26 | 2,915 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/5/23 20:58  | 5/4/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -191 | 10.90 | 0 | -18 | -85 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/23 17:02  | 2/27/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | M.d | 0 | 0.00 | 0 | 18 |  | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/23 17:02  | 2/27/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Chief Ac | S.d | -232 | 10.38 | 0 | -22 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/23 16:59  | 2/27/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 60 | 51 | 178 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/23 16:57  | 2/27/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP,CMO | M.d | 0 | 0.00 | 0 | 21 | 70 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/23 16:54  | 2/27/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 35 |  | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/23 16:52  | 2/27/23  | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 |  | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/8/22 16:41  | 12/6/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S | -17,400 | 11.60 | 0 | -1,500 | -28 | 3,915 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/10/22 16:54  | 11/8/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -651 | 12.47 | 0 | -52 | -96 | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/17/22 17:17  | 8/15/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S | -44,040 | 14.68 | 0 | -3,000 | -36 | 5,415 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:59  | 8/8/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 19 | 112 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:59  | 8/9/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -134 | 16.92 | 0 | -8 | -18 | 36 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:55  | 8/8/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 26 | 97 | 53 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:55  | 8/9/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -444 | 16.92 | 0 | -26 | -33 | 53 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:43  | 8/8/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 30 | 26 | 145 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:43  | 8/9/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | S.d | -252 | 16.92 | 0 | -15 | -9 | 145 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:21  | 8/8/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | M.d | 75 | 4.97 | 0 | 15 | 257 | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/22 20:21  | 8/8/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | S.d | -258 | 17.17 | 0 | -15 | -42 | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/22 18:16  | 5/16/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.d | 0 | 0.00 | 0 | 6 |  | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/22 18:16  | 5/17/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.d | -60 | 10.00 | 0 | -6 | -61 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 21:18  | 3/2/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 18 | 31 | 73 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 21:18  | 3/3/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -442 | 10.57 | 0 | -42 | -36 | 73 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 20:16  | 3/2/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 51 | 64 | 130 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 20:16  | 3/3/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | S.d | -878 | 10.56 | 0 | -83 | -39 | 130 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 20:04  | 3/2/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 10 | 68 | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 20:04  | 3/3/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -254 | 10.57 | 0 | -24 | -49 | 25 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 20:03  | 3/2/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.d | 0 | 0.00 | 0 | 21 |  | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/4/22 20:03  | 3/3/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.d | -227 | 10.58 | 0 | -21 | -85 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/22 21:16  | 2/10/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 53 | 119 | 97 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/22 21:13  | 2/10/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 30 | 362 | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/22 21:09  | 2/10/22  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 89 | 125 | 161 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/18/21 17:06  | 11/16/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.dm | 936 | 10.47 | 0 | 89 |  | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/18/21 17:06  | 11/16/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.dm | -1,530 | 17.11 | 0 | -89 | -92 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/2/21 17:30  | 11/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -402 | 20.12 | 0 | -20 | -31 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/8/21 17:59  | 10/7/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -54 | 18.00 | 0 | -3 | -4 | 64 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/5/21 19:04  | 10/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -310 | 18.23 | 0 | -17 | -20 | 67 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 17:00  | 9/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -400 | 19.99 | 0 | -20 | -19 | 84 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 17:00  | 9/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 9 | 10.47 | 0 | 1 | 12 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 17:00  | 9/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -18 | 20.15 | 0 | -1 | -10 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 17:00  | 9/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.d | 76 | 3.81 | 0 | 20 |  | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/3/21 17:00  | 9/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.d | -400 | 20.00 | 0 | -20 | -84 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/27/21 20:07  | 8/27/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S.d | -32,440 | 16.22 | 0 | -2,000 | -19 | 8,415 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/21 19:35  | 8/23/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 19 | 4.50 | 0 | 4 | 4 | 104 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/21 19:35  | 8/24/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S.d | -140 | 14.00 | 0 | -10 | -9 | 104 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/21 19:33  | 8/23/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Phillips Peggy V | CA | D |  | M.d | 19 | 4.50 | 0 | 4 | 18 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/21 19:32  | 8/24/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | M.d | 19 | 4.50 | 0 | 4 | 25 | 21 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/25/21 19:32  | 8/24/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S | -87 | 15.00 | 0 | -6 | -61 | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/21 19:11  | 8/16/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 16 | 5.42 | 0 | 3 | 54 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/21 19:11  | 8/16/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -36 | 12.36 | 0 | -3 | -26 | 8 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/13/21 18:59  | 8/11/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -120 | 12.00 | 0 | -10 | -9 | 107 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/13/21 18:58  | 8/11/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 269 | 5.42 | 0 | 50 |  | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/13/21 18:58  | 8/11/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.d | -598 | 12.06 | 0 | -50 | -88 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/11/21 18:26  | 8/9/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | S.d | -24,300 | 10.80 | 0 | -2,250 | -21 | 8,524 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/10/21 18:57  | 8/6/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S | -860 | 10.75 | 0 | -80 | -92 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/2/21 18:00  | 4/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | S | -198 | 9.92 | 0 | -20 | -15 | 117 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/26/21 18:46  | 2/26/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.adm | 0 | 0.00 | 0 | 10 |  | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/26/21 18:46  | 3/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.adm | -37 | 8.86 | 0 | -4 | -37 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/2/21 19:52  | 2/26/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | M.dm | 0 | 0.00 | 0 | 10 |  | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/2/21 19:52  | 3/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Burgess Justin | CA | O | Principa | S.dm | -37 | 8.86 | 0 | -4 | -37 | 7 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/21 20:39  | 2/22/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 21 | 43 | 70 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/3/21 18:28  | 2/1/21  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S | -449 | 10.64 | 0 | -42 | -33 | 86 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/20/20 19:42  | 7/17/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S | -555 | 11.09 | 0 | -50 | -28 | 127 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/28/20 17:13  | 5/27/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Hack Andrew A. F. | MA | D |  | P | 5,000 | 5.00 | 0 | 1,000 | 13 | 8,525 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/20 19:05  | 5/19/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S | -95 | 6.33 | 0 | -15 | -8 | 177 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/7/20 18:37  | 5/5/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | S.m | -166 | 4.50 | 0 | -37 | -16 | 192 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/25/20 19:42  | 2/22/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 0 | 9 | 6 | 162 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/25/20 19:40  | 2/22/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 9 | 7 | 132 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/25/20 19:35  | 2/22/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 27 | 93 | 57 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/25/20 19:32  | 2/22/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 22 | 47 | 68 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/25/20 19:28  | 2/22/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 9 | 4 | 229 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/25/20 19:22  | 2/12/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.ad | 0 | 0.00 | 0 | 26 | 13 | 219 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/20 18:46  | 2/12/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | M.d | 0 | 0.00 | 0 | 26 | 22 | 144 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/20 18:44  | 2/12/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 0 | 22 | 17 | 154 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/20 18:42  | 2/5/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 5 | 11 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/20 18:39  | 2/12/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 26 | 13 | 221 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/20 18:37  | 2/5/20  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 2 | 6 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/19 19:27  | 8/12/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Phillips Peggy V | CA | D |  | P.d | 50 | 3.00 | 0 | 17 | 121 | 30 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/19 19:24  | 8/12/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | P.d | 50 | 3.00 | 0 | 17 | New | 17 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/19 19:23  | 8/12/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | Co-P,SVP | P.d | 50 | 3.00 | 0 | 17 | 16 | 118 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:15  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 10 | 30 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:14  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | O | Co-P,SVP | M.d | 0 | 0.00 | 0 | 5 | 24 | 26 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:13  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 47 | 32 | 195 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:10  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | Co-P,SVP | M.d | 0 | 0.00 | 0 | 45 | 80 | 102 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:07  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 55 | 237 | 78 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:07  | 6/4/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | S.d | -148 | 4.58 | 0 | -32 | -29 | 78 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:05  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Gray Eddie | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 75 | 33 | 305 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:03  | 6/2/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 0 | 50 | 61 | 132 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:01  | 2/28/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.ad | 20 | 5.40 | 0 | 4 | 5 | 82 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/19 19:01  | 2/28/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | S.ad | -317 | 8.94 | 0 | -35 | -30 | 82 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/19 20:01  | 2/28/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | S | -188 | 9.03 | 0 | -21 | -39 | 32 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/19 19:57  | 2/28/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | S | -571 | 9.03 | 0 | -63 | -45 | 78 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/19 19:55  | 2/28/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 20 | 5.40 | 0 | 4 | 5 | 87 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/19 19:55  | 2/28/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | S.d | -317 | 8.94 | 0 | -35 | -29 | 87 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/19 19:46  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.ad | 0 | 0.00 | 0 | 58 | 72 | 140 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/19 19:35  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 16 | 38 | 58 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/19 19:34  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 55 | 60 | 148 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/19 19:33  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 0 | 58 | 76 | 135 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/19 19:33  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | M.d | 0 | 0.00 | 0 | 54 | 239 | 76 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/19 19:32  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Gray Eddie | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 112 | 70 | 271 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/19 19:31  | 2/22/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 63 | 81 | 141 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/7/19 18:11  | 2/5/19  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 5 | 13 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/19 20:34  | 12/31/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 15 | 68 | 37 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/7/18 19:23  | 12/6/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Cano Francis | CA | D |  | S | -21 | 10.47 | 0 | -2 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/8/18 19:37  | 6/8/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | S | -62 | 15.53 | 0 | -4 | -5 | 77 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/18 19:53  | 6/2/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 0 | 50 | 89 | 106 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/18 19:52  | 6/2/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | M.d | 0 | 0.00 | 0 | 45 | New | 45 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/18 19:51  | 6/2/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 10 | 61 | 26 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/18 19:50  | 6/2/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 47 | 68 | 116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/18 19:40  | 6/2/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Gray Eddie | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 75 | 62 | 197 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/4/18 19:39  | 6/2/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 55 | 108 | 105 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/16/18 16:40  | 3/15/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | S | -263 | 16.30 | 0 | -16 | -100 | 0 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/15/18 19:45  | 3/13/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | S | -565 | 16.52 | 0 | -34 | -68 | 16 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/15/18 19:23  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | M.ad | 0 | 0.00 | 0 | 60 | 424 | 74 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/13/18 18:56  | 3/9/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | S | -38 | 17.97 | 0 | -2 | -3 | 76 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 20:04  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 62 | 207 | 92 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 20:03  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 16 | 220 | 23 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 20:02  | 1/4/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | S.a | -58 | 18.60 | 0 | -3 | -54 | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 20:00  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | M.d | 0 | 0.00 | 0 | 60 | 344 | 78 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 19:58  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | M.d | 0 | 0.00 | 0 | 70 | 999% | 76 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 19:57  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 0 | 65 | 442 | 79 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/23/18 19:55  | 2/22/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Gray Eddie | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 0 | 140 | 393 | 175 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/18 19:29  | 2/5/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 5 | 99 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/5/18 16:35  | 1/4/18  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | S | -58 | 18.60 | 0 | -3 | -40 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/18 20:02  | 12/31/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 0 | 5 | 107 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/15/17 16:47  | 12/13/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | M.d | 41 | 5.40 | 0 | 8 |  | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/15/17 16:47  | 12/13/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Coffman Robert | CA | O | SVP | S.d | -142 | 18.90 | 0 | -8 | -54 | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/15/17 20:43  | 3/14/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Ostrach Michael S | CA | O | SVP | M.d | 0 | 0.00 | 14 | 10 | 215 | 15 | D | -74 | -67 | -53 | 24 | 40 | 44 | -8 | -3 | 3 | -2 | -5 |  |  |  | 
3/15/17 20:40  | 3/14/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | VP | M.d | 0 | 0.00 | 14 | 10 | 69 | 25 | D | -74 | -67 | -53 | 24 | 40 | 44 | -8 | -3 | 3 | -2 | -5 |  |  |  | 
3/15/17 20:37  | 3/14/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | SVP | M.d | 0 | 0.00 | 14 | 20 |  | 14 | D | -74 | -67 | -53 | 24 | 40 | 44 | -8 | -3 | 3 | -2 | -5 |  |  |  | 
2/7/17 18:47  | 2/4/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Gray Eddie | CA | DO | CEO,Dir | M.d | 0 | 0.00 | 3 | 50 |  | 36 | D | -75 | -81 | -75 | -55 | 1 | -5 | 8 | 3 | 1 | 1 | 46 | 35 |  |  | 
2/7/17 18:45  | 2/5/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Johnson David Louis | CA | O | VP | M.d | 0 | 0.00 | 3 | 5 |  | 3 | D | -75 | -81 | -75 | -55 | 1 | -5 | 8 | 3 | 1 | 1 | 46 | 35 |  |  | 
1/26/17 19:11  | 1/24/17  | DVAX | Health | Drug | Pharmaceutical Preparations | Janssen Robert | CA | O | VP | P | 24 | 4.04 | 4 | 6 | 99 | 12 | D | -79 | -85 | -73 | -61 | -11 | -10 | -9 | -7 | 3 | 5 | 6 | 49 |  |  |